Maria Giubettini
Maria Giubettini has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Grimaldi
Multiple Sclerosis Clinical and Research Unit, Fondazione Policlinico di Tor Vergata, 00133 Rome, Italy
1 shared publication - Andrea Musacchio
Max Planck Institute of Molecular Physiology
1 shared publication - Barbara Cortese
National Research Council - Institute of Nanotechnology (CNR Nanotec), c/o Department of Physics “E. Fermi”, University Sapienza, Rome, Italy
1 shared publication - Bernadette Basilico
Department of Physiology and Pharmacology, Sapienza University, Rome, Italy
1 shared publication Carlo Brighi
CrestOptics S.p.a. , Rome
1 shared publication- Carolin Koerner
Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany
1 shared publication
Latest Publications
- Open Access
- 25 September 2024
- Published by Oxford University Press (OUP) in Microscopy Today
- Vol. 32 (5) , 38-42
Unlocking the Potential of the CICERO Spinning Disk System: Exploring Diverse Applications
CrestOptics aims to make their products accessible to researchers, enabling a variety of applications, and to create products that are both efficient and user-friendly. The CICERO confocal spinning disk system embodies these principles, designed for easy integration into any imaging setup. Its compactness and flexibility make advanced fluorescence microscopy accessible to laboratories worldwide. This article will focus on the great versatility and strengths of the CICERO system, which is a complete widefield (WF) and spinning disk confocal (CF) solution. It will demonstrate its key features, namely its use on both inverted and upright microscopy configurations, its wide spectral range, the high resolution and sectioning power, and its large field of view (FOV). Microscopy Today has awarded CICERO a 2024 Innovation Award for these features.
- 25 September 2024
- Published by Oxford University Press (OUP) in Microscopy Today
- Vol. 32 (5) , 38-42
Open AccessUnlocking the Potential of the CICERO Spinning Disk System: Exploring Diverse Applications
CrestOptics aims to make their products accessible to researchers, enabling a variety of applications, and to create products that are both efficient and user-friendly. The CICERO confocal spinning disk system embodies these principles, designed for easy integration into any imaging setup. Its compactness and flexibility make advanced fluorescence microscopy accessible to laboratories worldwide. This article will focus on the great versatility and strengths of the CICERO system, which is a complete widefield (WF) and spinning disk confocal (CF) solution. It will demonstrate its key features, namely its use on both inverted and upright microscopy configurations, its wide spectral range, the high resolution and sectioning power, and its large field of view (FOV). Microscopy Today has awarded CICERO a 2024 Innovation Award for these features.
- Open Access
Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2
Conjugation with the small ubiquitin-like modifier (SUMO) modulates protein interactions and localisation. The kinase Aurora B, a key regulator of mitosis, was previously identified as a SUMOylation target in vitro and in assays with overexpressed components. However, where and when this modification genuinely occurs in human cells was not ascertained. Here, we have developed intramolecular Proximity Ligation Assays (PLA) to visualise SUMO-conjugated Aurora B in human cells in situ. We visualised Aurora B-SUMO products at centromeres in prometaphase and metaphase, which declined from anaphase onwards and became virtually undetectable at cytokinesis. In the mitotic window in which Aurora B/SUMO products are abundant, Aurora B co-localised and interacted with NUP358/RANBP2, a nucleoporin with SUMO ligase and SUMO-stabilising activity. Indeed, in addition to the requirement for the previously identified PIAS3 SUMO ligase, we found that NUP358/RANBP2 is also implicated in Aurora B-SUMO PLA product formation and centromere localisation. In summary, SUMOylation marks a distinctive window of Aurora B functions at centromeres in prometaphase and metaphase while being dispensable for functions exerted in cytokinesis, and RANBP2 contributes to this control, adding a novel layer to modulation of Aurora B functions during mitosis.
Open AccessAurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2
Conjugation with the small ubiquitin-like modifier (SUMO) modulates protein interactions and localisation. The kinase Aurora B, a key regulator of mitosis, was previously identified as a SUMOylation target in vitro and in assays with overexpressed components. However, where and when this modification genuinely occurs in human cells was not ascertained. Here, we have developed intramolecular Proximity Ligation Assays (PLA) to visualise SUMO-conjugated Aurora B in human cells in situ. We visualised Aurora B-SUMO products at centromeres in prometaphase and metaphase, which declined from anaphase onwards and became virtually undetectable at cytokinesis. In the mitotic window in which Aurora B/SUMO products are abundant, Aurora B co-localised and interacted with NUP358/RANBP2, a nucleoporin with SUMO ligase and SUMO-stabilising activity. Indeed, in addition to the requirement for the previously identified PIAS3 SUMO ligase, we found that NUP358/RANBP2 is also implicated in Aurora B-SUMO PLA product formation and centromere localisation. In summary, SUMOylation marks a distinctive window of Aurora B functions at centromeres in prometaphase and metaphase while being dispensable for functions exerted in cytokinesis, and RANBP2 contributes to this control, adding a novel layer to modulation of Aurora B functions during mitosis.
- Open Access
Antibiotics Treatment Modulates Microglia–Synapses Interaction
‘Dysbiosis’ of the adult gut microbiota, in response to challenges such as infection, altered diet, stress, and antibiotics treatment has been recently linked to pathological alteration of brain function and behavior. Moreover, gut microbiota composition constantly controls microglia maturation, as revealed by morphological observations and gene expression analysis. However, it is unclear whether microglia functional properties and crosstalk with neurons, known to shape and modulate synaptic development and function, are influenced by the gut microbiota. Here, we investigated how antibiotic-mediated alteration of the gut microbiota influences microglial and neuronal functions in adult mice hippocampus. Hippocampal microglia from adult mice treated with oral antibiotics exhibited increased microglia density, altered basal patrolling activity, and impaired process rearrangement in response to damage. Patch clamp recordings at CA3-CA1 synapses revealed that antibiotics treatment alters neuronal functions, reducing spontaneous postsynaptic glutamatergic currents and decreasing synaptic connectivity, without reducing dendritic spines density. Antibiotics treatment was unable to modulate synaptic function in CX3CR1-deficient mice, pointing to an involvement of microglia–neuron crosstalk through the CX3CL1/CX3CR1 axis in the effect of dysbiosis on neuronal functions. Together, our findings show that antibiotic alteration of gut microbiota impairs synaptic efficacy, suggesting that CX3CL1/CX3CR1 signaling supporting microglia is a major player in in the gut–brain axis, and in particular in the gut microbiota-to-neuron communication pathway.
Open AccessAntibiotics Treatment Modulates Microglia–Synapses Interaction
‘Dysbiosis’ of the adult gut microbiota, in response to challenges such as infection, altered diet, stress, and antibiotics treatment has been recently linked to pathological alteration of brain function and behavior. Moreover, gut microbiota composition constantly controls microglia maturation, as revealed by morphological observations and gene expression analysis. However, it is unclear whether microglia functional properties and crosstalk with neurons, known to shape and modulate synaptic development and function, are influenced by the gut microbiota. Here, we investigated how antibiotic-mediated alteration of the gut microbiota influences microglial and neuronal functions in adult mice hippocampus. Hippocampal microglia from adult mice treated with oral antibiotics exhibited increased microglia density, altered basal patrolling activity, and impaired process rearrangement in response to damage. Patch clamp recordings at CA3-CA1 synapses revealed that antibiotics treatment alters neuronal functions, reducing spontaneous postsynaptic glutamatergic currents and decreasing synaptic connectivity, without reducing dendritic spines density. Antibiotics treatment was unable to modulate synaptic function in CX3CR1-deficient mice, pointing to an involvement of microglia–neuron crosstalk through the CX3CL1/CX3CR1 axis in the effect of dysbiosis on neuronal functions. Together, our findings show that antibiotic alteration of gut microbiota impairs synaptic efficacy, suggesting that CX3CL1/CX3CR1 signaling supporting microglia is a major player in in the gut–brain axis, and in particular in the gut microbiota-to-neuron communication pathway.